A double‐blind, randomized, placebo‐controlled trial of ursodeoxycholic acid (UDCA) in Parkinson's disease

Payne, T., Appleby, M., Buckley, E. et al. (16 more authors) (2023) A double‐blind, randomized, placebo‐controlled trial of ursodeoxycholic acid (UDCA) in Parkinson's disease. Movement Disorders, 38 (8). pp. 1493-1502. ISSN 0885-3185

Abstract

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2023 The Authors. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. https://creativecommons.org/licenses/by-nc-nd/4.0/

Keywords: 31P-MR spectroscopy; UDCA; neuroprotection; supervised gait analysis; ursodeoxycholic acid
Dates:
  • Published: August 2023
  • Published (online): 29 May 2023
  • Accepted: 3 May 2023
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Department of Neuroscience (Sheffield)
Funding Information:
Funder
Grant number
Alzheimer’s Research UK
ARUK-SRF2017B-1
Depositing User: Symplectic Sheffield
Date Deposited: 07 Jun 2023 16:00
Last Modified: 03 Oct 2024 15:49
Status: Published
Publisher: Wiley
Refereed: Yes
Identification Number: 10.1002/mds.29450
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics